ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,482Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 22

$1.13M Total Retail Price of All Prescriptions

Rank: 1 out of 22

856 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 7,496 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

50% of this provider’s prescriptions were for brand-name drugs, compared to an average of 42%.

Prescription Price

$119 was the average price of a prescription from this provider, compared to $91 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SYNTHROID 998 834 1 2
METFORMIN HCL ER 795 614 10 2 7
GLIMEPIRIDE 623 584 3 5
METFORMIN HCL 544 420 4 3
LEVOXYL 524 429 5 12
NOVOLOG MIX 70-30 FLEXPEN 370 325 10 6 29
INSULIN SYRINGE 366 258 7 6
PEN NEEDLE 324 246 8 9
JANUVIA 288 271 9 14
LANTUS 215 134 10 8
LEVOTHYROXINE SODIUM 215 162 10 1
SIMVASTATIN 212 139 12 4
LANTUS SOLOSTAR 211 169 13 15
NOVOLOG MIX 70-30 198 136 14 40
HUMALOG 197 110 15 16
HUMALOG MIX 75-25 189 162 16 28
ATORVASTATIN CALCIUM 180 123 17 11
HUMULIN 70-30 179 175 18 36
HUMULIN R 160 95 19 37
PRAVASTATIN SODIUM 143 111 20 19
NOVOLOG FLEXPEN 137 88 21 44
ONGLYZA 117 114 22 43
GLYBURIDE-METFORMIN HCL 100 92 R 23 42
NOVOLIN 70-30 90 82 24 52
GABAPENTIN 90 81 24 35
ALENDRONATE SODIUM 89 88 26 32
LISINOPRIL 87 65 27 10
LEVEMIR FLEXPEN 80 52 28 34
GLIPIZIDE XL 78 78 29 39
CRESTOR 73 23 30 27
GLIPIZIDE ER 72 67 31 24
FENOFIBRATE 72 41 31 38
NOVOFINE 66 63 33 105
NOVOLOG 65 39 34 45
NATEGLINIDE 62 62 35 107
NOVOFINE 32 61 53 36 74
METHIMAZOLE 58 55 37 30
RAMIPRIL 57 40 38 112
LOSARTAN POTASSIUM 55 49 39 20
QUINAPRIL HCL 52 34 40 57
LIPITOR 51 41 41 53
BYETTA 50 50 42 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.